Purpose: Monitoring of amphotericin-B (AmB) in Saudi critically ill patients in ICU after IV administration of 0.5-0.75 mg/kg/day AmB as Fungizone. Developing a fast, robust, selective, sensitive, and precise UPLC MS/MS method, to study the pharmacokinetics of AmB in these patients.